The Centers for Disease Control and Prevention has issued an advisory alerting health care providers, laboratory professionals and others in health care settings of a critical shortage of Becton Dickinson BACTEC blood culture bottles. The shortage could lead to significant disruptions in patient care, including diagnosis delays or make the management of patients with infectious diseases more difficult, according to CDC. The agency is recommending laboratory professionals and clinical leaders in health care facilities that are affected implement plans for conserving available supply and develop options to mitigate the impact on patient care. 
 

Related News Articles

Headline
The AHA Oct. 28 issued a Special Bulletin to members informing them of the Food and Drug Administration's authorization extending the use date for certain…
Headline
The Centers for Disease Control and Prevention has issued a health advisory on the supply disruption of peritoneal dialysis and intravenous solutions due to…
Headline
Baxter announced that it is increasing the current U.S. allocation levels of its highest-demand IV fluids for direct customers from 40% to 60%, and for…